University of New South Wales, Kensington, New South Wales, Australia.
J Virol. 2013 Mar;87(6):3376-81. doi: 10.1128/JVI.02821-12. Epub 2013 Jan 9.
Calculation of pathogen growth rates is important in understanding the natural history of infection and effects of therapy. However, it is often difficult to estimate pathogen growth because patients are treated immediately upon the detection of infection, leaving only one nonzero untreated reading. Previous approaches have relied on the flawed assumption that pathogen loads just prior to detection are at the assay detection threshold. We have developed a novel method for estimating the pathogen growth rate from a single reading and investigated the initial growth of cytomegalovirus (CMV) in allogeneic hematopoietic stem cell transplant (HSCT) patients. We applied this approach to CMV viral loads measured at least weekly in 122 patients in the 3 months posttransplant. Viral growth rates were estimated by using a modeling approach that accounts for the viral load and the time since the last negative reading. Viral growth rates decreased rapidly within the first week, from 0.72/day (doubling time, 0.96 day) at the point of reactivation to 0.22/day (doubling time, 3.1 days) at 1 week. Results from this method correlated closely with a two-point regression analysis of a subset of 58 patients with detectable subthreshold viral loads immediately prior to overt reactivation. Patients with lymphocyte counts of ≥0.5 × 10(9)/liter had significantly slower viral growth than patients with low lymphocyte counts (0.612/day versus 0.325/day, P < 0.0001). Thus, our novel method of estimating pathogen growth rates reveals a rapid slowing of CMV growth during reactivation in HSCT patients and a significant impact of the lymphocyte count on CMV growth.
计算病原体增长率对于了解感染的自然史和治疗效果非常重要。然而,由于患者在感染检测后立即接受治疗,因此仅存在一个非零的未治疗读数,因此通常难以估计病原体的增长率。先前的方法依赖于一个有缺陷的假设,即检测前的病原体载量处于检测阈值。我们开发了一种从单个读数估算病原体增长率的新方法,并研究了异基因造血干细胞移植 (HSCT) 患者中巨细胞病毒 (CMV) 的初始生长情况。我们将这种方法应用于 122 例患者在移植后 3 个月内每周至少测量一次的 CMV 病毒载量。通过使用一种考虑病毒载量和上次阴性读数后时间的建模方法来估算病毒增长率。在最初的一周内,病毒增长率迅速下降,从再激活时的 0.72/天(倍增时间为 0.96 天)降至 1 周时的 0.22/天(倍增时间为 3.1 天)。该方法的结果与对 58 例在明显再激活前有可检测到的亚阈值病毒载量的患者的亚组进行的两点回归分析密切相关。淋巴细胞计数≥0.5×10(9)/升的患者的病毒增长率明显慢于淋巴细胞计数低的患者(0.612/天比 0.325/天,P<0.0001)。因此,我们估算病原体增长率的新方法揭示了 HSCT 患者再激活期间 CMV 生长的迅速减缓,以及淋巴细胞计数对 CMV 生长的显著影响。